Clinical Trials
All Clinical Trials - Page 51 of 52
A complete, crawlable index of every tracked clinical trial of peptide compounds. Use the search browser at /trials for filtering, or page through the full list here.
- NCT00064714Phase 2Completed
Effect of AC2993 With or Without Immunosuppression on Beta Cell Function in Patients With Type I Diabetes
Exenatide
- NCT00082381Phase 3Completed
Effect of AC2993 Compared With Insulin Glargine in Patients With Type 2 Diabetes Also Using Combination Therapy With Sulfonylurea and Metformin
Exenatide
- NCT00582556Phase 2Completed
Zometa on Bone Mineral Density in Prostate Cancer Patients Undergoing Androgen Ablation Therapy
Gonadorelin
- NCT00056654N/ACompleted
Study of a 6-Month Sustained-Release Formulation of Leuprolide Acetate in Prostate Cancer
Gonadorelin
- NCT00363285Phase 3Unknown
Cyproterone Acetate in Treating Patients With Newly Diagnosed Stage III or Stage IV Prostate Cancer
Gonadorelin
- NCT01620463Phase 1Completed
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Liraglutide in Healthy Japanese Volunteers
Liraglutide
- NCT00429494Phase 2Completed
GnRH Analogue for Ovarian Function Preservation in Hematopoietic Stem Cell Transplantation Patients
Gonadorelin
- NCT00053911Phase 3Terminated
Combination Chemotherapy Compared With Observation After Surgery in Treating Women With Relapsed Nonmetastatic Breast Cancer
Gonadorelin
- NCT00111540Phase 3Completed
Study to Examine the Effect on Glucose Control and Safety/Tolerability of Exenatide Given Two Times a Day to Subjects With Type 2 Diabetes
Exenatide
- NCT00199485Phase 4Completed
Angelica Sinensis for the Treatment of Hot Flashes in Men Undergoing LHRH Therapy for Prostate Cancer
Gonadorelin
- NCT01789957Phase 3Completed
Extension Study for 2993-112
Exenatide
- NCT01511172Phase 2Completed
Effect of Liraglutide as add-on to Metformin Compared to Either Liraglutide or Metformin Alone, or to a Combination of Metformin and a SU (Sulphonylurea) Agent in Subjects With Type 2 Diabetes
Liraglutide
- NCT00044668Phase 3Completed
Evaluation of the Effect on Glucose Control and Safety of AC2993 in Patients With Type 2 Diabetes Treated With Metformin, Sulfonylurea, or Metformin and Sulfonylurea Combination
Exenatide
- NCT00044694Phase 2Completed
Evaluation of the Effect on Glucose Control and the Safety and Tolerability of AC2993 in Patients With Type 2 Diabetes Mellitus
Exenatide
- NCT00911443Phase 2Completed
Thymosin Alpha 1, Interferon Alpha, or Both, in Combination With Dacarbazine in Patients With Malignant Melanoma
Thymosin-Alpha-1
- NCT01160315Phase 2/Phase 3Completed
Efficiency of Gonadotropin-releasing Hormone (GnRH) Agonist in Preventing Chemotherapy Induced Ovarian Failure
Gonadorelin
- NCT00039962Phase 3Completed
Thymosin Plus PEG-Interferon in Hepatitis C Patients With Cirrhosis Who Did Not Respond to Interferon or Interferon Plus Ribavirin
Thymosin-Alpha-1
- NCT00035984Phase 3Completed
Evaluation of the Effect on Glucose Control of AC2993 in Patients With Type 2 Diabetes Mellitus
Exenatide
- NCT00040027Phase 3Completed
Thymosin Plus PEG-Interferon in Non-Cirrhotic Hepatitis C Patients Who Did Not Respond to Interferon or Interferon Plus Ribavirin
Thymosin-Alpha-1
- NCT00283803Phase 2Completed
Exisulind and Intermittent Androgen Suppression (ADT) in Biochemical Relapsed Prostate Cancer
Gonadorelin
- NCT00653757Phase 1/Phase 2Completed
Intensity-Modulated Radiation Therapy in Treating Patients With Stage I, Stage II, Stage III, or Stage IV Prostate Cancer
Gonadorelin
- NCT00039013Phase 3Completed
Evaluation of the Effect on Glucose Control of AC2993 in Patients With Type 2 Diabetes Mellitus Treated With Metformin
Exenatide
- NCT01264497Phase 2Completed
Safety Study of TH9507 in Subjects With Stable, Type 2 Diabetes
Tesamorelin
- NCT00039026Phase 3Completed
Evaluation of the Effect on Glucose Control of AC2993 in Patients With Type 2 Diabetes Mellitus Treated With a Sulfonylurea
Exenatide
- NCT00026377Phase 1Completed
SU5416 Plus Hormone Therapy and Radiation Therapy in Treating Patients With Prostate Cancer
Gonadorelin
- NCT01511159Phase 1Completed
Comparison of Liraglutide Inhaled Into the Lungs Compared to Liraglutide Injected Under the Skin in Healthy Male Volunteers
Liraglutide
- NCT01508949Phase 2Completed
Effect of Liraglutide on Weight and Appetite in Obese Subjects With Type 2 Diabetes
Liraglutide
- NCT03018886N/ACompleted
Diagnosing Adult Growth Hormone Deficiency
Sermorelin
- NCT01508923Phase 2Completed
Effect of Liraglutide on Glucose Profiles and Gastric Emptying in Subjects With Type 2 Diabetes
Liraglutide
- NCT00064987Phase 2Terminated
Follicle Stimulating Hormone (FSH) to Improve Testicular Development in Men With Hypogonadism
Gonadorelin
- NCT00021450Phase 3Completed
Radiation Therapy With or Without Bicalutamide and Goserelin in Treating Patients With Prostate Cancer
Gonadorelin
- NCT01509742Phase 1Completed
Effect of Liraglutide on Glucagon Secretion in Subjects With Type 2 Diabetes
Liraglutide
- NCT01511185Phase 1Completed
Effect of Liraglutide on the Beta-cell Responsiveness in Subjects With Type 2 Diabetes Compared to a Healthy Control Group
Liraglutide
- NCT01511198Phase 2Completed
Efficacy and Safety of Metformin and Liraglutide in Obese Subjects With Type 2 Diabetes Previously Treated With an Oral Hypoglycemic Agent
Liraglutide
- NCT01509755Phase 2Completed
Comparison of Liraglutide and Glimepiride on Blood Sugar Control in Subjects With Type 2 Diabetes
Liraglutide
- NCT00012090Phase 2Completed
Bicalutamide and Goserelin in Treating Patients With Cancer of the Ovary, Fallopian Tube, or Peritoneum
Gonadorelin
- NCT00004635Phase 3Completed
Thalidomide for the Treatment of Hormone-Dependent Prostate Cancer
Gonadorelin
- NCT00031850N/ACompleted
Raloxifene and Goserelin in Preventing Breast Cancer in Women With a Family History of Breast Cancer
Gonadorelin
- NCT00536653N/ACompleted
Changes in Bone Mineral Density and Fracture Risk in Patients Receiving Androgen Deprivation Therapy for Prostate Cancer
Gonadorelin
- NCT01507311Phase 1Completed
Effect of Liraglutide on Pulsatile Insulin Secretion in Subjects With Type 2 Diabetes
Liraglutide
- NCT01507285Phase 1Completed
Safety and Tolerability of Liraglutide in Healthy Volunteers and Subjects With Type 2 Diabetes
Liraglutide
- NCT01507272Phase 1Completed
Safety and Tolerability of Liraglutide in Healthy Male Volunteers
Liraglutide
- NCT00841113Phase 3Completed
Abarelix Versus Goserelin Plus Bicalutamide in Patients With Advanced or Metastatic Prostate Cancer
Sermorelin
- NCT00003734Phase 3Unknown
Combination Hormone Therapy Followed by Radiation Therapy in Treating Patients With Prostate Cancer
Gonadorelin
- NCT00002889Phase 2Completed
Radiation Therapy With Androgen Suppression in Treating Patients With Prostate Cancer
Gonadorelin
- NCT00003026Phase 3Completed
Hormone Therapy in Treating Patients With Advanced Prostate Cancer
Gonadorelin
- NCT00004344N/ACompleted
Purification of Testis-Stimulating Factor in Precocious Puberty
Gonadorelin
- NCT00817739Phase 2Completed
Intermittent Hormonal Therapy With Leuprorelin and Flutamide in the Treatment of Stage D2 or TxNxM1b,c
Gonadorelin
- NCT00000380N/ACompleted
Growth Hormone Releasing Hormone (GHRH) Treatment for Age-Related Sleep Disturbances
Sermorelin
- NCT00001481Phase 2Completed
The Role of Hormones in Postpartum Mood Disorders
Gonadorelin